Summary

The global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software market is projected to grow from US$ 198 million in 2025 to US$ 337 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
The market covers AI-enabled medical software used to analyze acute stroke imaging and support time-sensitive clinical decisions across non-contrast CT, CT angiography, CT perfusion and MRI workflows. Products typically apply machine learning or related computational methods to identify and quantify intracranial hemorrhage, ischemic change and vessel occlusion, calculate ASPECTS, characterize perfusion and tissue viability, prioritize urgent cases, and support thrombolysis, thrombectomy and interhospital transfer decisions. The market is centered on regulated clinical software deployed through hospital imaging systems, cloud or edge infrastructure, dedicated workstations and mobile workflow applications. It includes standalone algorithms and multimodule stroke platforms whose economic value is generated from diagnostic imaging analysis, decision support and stroke-network workflow coordination.
From a downstream perspective, Pre-Hospital Emergency Care accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software leading players (including RapidAI, Viz.ai, Brainomix, Aidoc, JLK, Qure.ai, United Imaging Intelligence, Infervision, Shukun Technology, Heuron, etc.), dominate supply; the top five capture approximately % of global revenue, with RapidAI leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
RapidAI
Viz.ai
Brainomix
Aidoc
JLK
Qure.ai
United Imaging Intelligence
Infervision
Shukun Technology
Heuron
Siemens Healthineers
Circle CVI
Avicenna.AI
Nicolab
icometrix
Harrison.ai
Deepwise
Neusoft Medical
BioMind
GE HealthCare
Philips
Olea Medical
Methinks AI
Cercare Medical
PurpleAI
Coreline Soft
mlHealth 360
NeuroCareAI
DEEPNOID
Yiwei Medical
UnionStrong
Cerebriu
BrainScan
EverFortune.AI
Nunaps
SberMedAI
NtechLab
Celsus
Third Opinion
Hevi AI
CerebraAI
Sciberia
Radiomics & Machines
Sirona Medical
Segment by Type
Non-Contrast CT Software
CT Angiography Software
CT Perfusion Software
MRI Software
Segment by Types of Stroke
Ischemic Stroke Analysis Software
Hemorrhagic Stroke Analysis Software
Comprehensive Stroke Analysis Software
Segment by Application
Pre-Hospital Emergency Care
Hospital Stroke Center
Primary Healthcare Institutions
Regional Stroke Collaborative Treatment Network
Segment by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Non-Contrast CT Software
1.2.3 CT Angiography Software
1.2.4 CT Perfusion Software
1.2.5 MRI Software
1.3 Market Segmentation by Types of Stroke
1.3.1 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Types of Stroke, 2021 vs 2025 vs 2032
1.3.2 Ischemic Stroke Analysis Software
1.3.3 Hemorrhagic Stroke Analysis Software
1.3.4 Comprehensive Stroke Analysis Software
1.4 Market Segmentation by Application
1.4.1 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Application, 2021 vs 2025 vs 2032
1.4.2 Pre-Hospital Emergency Care
1.4.3 Hospital Stroke Center
1.4.4 Primary Healthcare Institutions
1.4.5 Regional Stroke Collaborative Treatment Network
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue Estimates and Forecasts (2021-2032)
2.2 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competitive Landscape
3.1 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Non-Contrast CT Software: Market Share by Key Players
3.3.2 CT Angiography Software: Market Share by Key Players
3.3.3 CT Perfusion Software: Market Share by Key Players
3.3.4 MRI Software: Market Share by Key Players
3.4 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Product Segmentation
4.1 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market by Types of Stroke
4.2.1 Global Revenue by Types of Stroke (2021-2032)
4.2.2 Global Revenue-Based Market Share by Types of Stroke (2021-2032)
4.3 Key Product Attributes and Differentiation
4.4 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.4.1 High-Growth Niches and Adoption Drivers
4.4.2 Profitability Hotspots and Cost Drivers
4.4.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application

6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico

7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia

8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore

9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 RapidAI
11.1.1 RapidAI Corporation Information
11.1.2 RapidAI Business Overview
11.1.3 RapidAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.1.4 RapidAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.1.5 RapidAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Product in 2025
11.1.6 RapidAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Application in 2025
11.1.7 RapidAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Geographic Area in 2025
11.1.8 RapidAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software SWOT Analysis
11.1.9 RapidAI Recent Developments
11.2 Viz.ai
11.2.1 Viz.ai Corporation Information
11.2.2 Viz.ai Business Overview
11.2.3 Viz.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.2.4 Viz.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.2.5 Viz.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Product in 2025
11.2.6 Viz.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Application in 2025
11.2.7 Viz.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Geographic Area in 2025
11.2.8 Viz.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software SWOT Analysis
11.2.9 Viz.ai Recent Developments
11.3 Brainomix
11.3.1 Brainomix Corporation Information
11.3.2 Brainomix Business Overview
11.3.3 Brainomix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.3.4 Brainomix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.3.5 Brainomix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Product in 2025
11.3.6 Brainomix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Application in 2025
11.3.7 Brainomix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Geographic Area in 2025
11.3.8 Brainomix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software SWOT Analysis
11.3.9 Brainomix Recent Developments
11.4 Aidoc
11.4.1 Aidoc Corporation Information
11.4.2 Aidoc Business Overview
11.4.3 Aidoc AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.4.4 Aidoc AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.4.5 Aidoc AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Product in 2025
11.4.6 Aidoc AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Application in 2025
11.4.7 Aidoc AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Geographic Area in 2025
11.4.8 Aidoc AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software SWOT Analysis
11.4.9 Aidoc Recent Developments
11.5 JLK
11.5.1 JLK Corporation Information
11.5.2 JLK Business Overview
11.5.3 JLK AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.5.4 JLK AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.5.5 JLK AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Product in 2025
11.5.6 JLK AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Application in 2025
11.5.7 JLK AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Geographic Area in 2025
11.5.8 JLK AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software SWOT Analysis
11.5.9 JLK Recent Developments
11.6 Qure.ai
11.6.1 Qure.ai Corporation Information
11.6.2 Qure.ai Business Overview
11.6.3 Qure.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.6.4 Qure.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.6.5 Qure.ai Recent Developments
11.7 United Imaging Intelligence
11.7.1 United Imaging Intelligence Corporation Information
11.7.2 United Imaging Intelligence Business Overview
11.7.3 United Imaging Intelligence AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.7.4 United Imaging Intelligence AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.7.5 United Imaging Intelligence Recent Developments
11.8 Infervision
11.8.1 Infervision Corporation Information
11.8.2 Infervision Business Overview
11.8.3 Infervision AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.8.4 Infervision AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.8.5 Infervision Recent Developments
11.9 Shukun Technology
11.9.1 Shukun Technology Corporation Information
11.9.2 Shukun Technology Business Overview
11.9.3 Shukun Technology AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.9.4 Shukun Technology AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.9.5 Shukun Technology Recent Developments
11.10 Heuron
11.10.1 Heuron Corporation Information
11.10.2 Heuron Business Overview
11.10.3 Heuron AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.10.4 Heuron AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Siemens Healthineers
11.11.1 Siemens Healthineers Corporation Information
11.11.2 Siemens Healthineers Business Overview
11.11.3 Siemens Healthineers AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.11.4 Siemens Healthineers AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.11.5 Siemens Healthineers Recent Developments
11.12 Circle CVI
11.12.1 Circle CVI Corporation Information
11.12.2 Circle CVI Business Overview
11.12.3 Circle CVI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.12.4 Circle CVI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.12.5 Circle CVI Recent Developments
11.13 Avicenna.AI
11.13.1 Avicenna.AI Corporation Information
11.13.2 Avicenna.AI Business Overview
11.13.3 Avicenna.AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.13.4 Avicenna.AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.13.5 Avicenna.AI Recent Developments
11.14 Nicolab
11.14.1 Nicolab Corporation Information
11.14.2 Nicolab Business Overview
11.14.3 Nicolab AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.14.4 Nicolab AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.14.5 Nicolab Recent Developments
11.15 icometrix
11.15.1 icometrix Corporation Information
11.15.2 icometrix Business Overview
11.15.3 icometrix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.15.4 icometrix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.15.5 icometrix Recent Developments
11.16 Harrison.ai
11.16.1 Harrison.ai Corporation Information
11.16.2 Harrison.ai Business Overview
11.16.3 Harrison.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.16.4 Harrison.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.16.5 Harrison.ai Recent Developments
11.17 Deepwise
11.17.1 Deepwise Corporation Information
11.17.2 Deepwise Business Overview
11.17.3 Deepwise AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.17.4 Deepwise AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.17.5 Deepwise Recent Developments
11.18 Neusoft Medical
11.18.1 Neusoft Medical Corporation Information
11.18.2 Neusoft Medical Business Overview
11.18.3 Neusoft Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.18.4 Neusoft Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.18.5 Neusoft Medical Recent Developments
11.19 BioMind
11.19.1 BioMind Corporation Information
11.19.2 BioMind Business Overview
11.19.3 BioMind AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.19.4 BioMind AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.19.5 BioMind Recent Developments
11.20 GE HealthCare
11.20.1 GE HealthCare Corporation Information
11.20.2 GE HealthCare Business Overview
11.20.3 GE HealthCare AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.20.4 GE HealthCare AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.20.5 GE HealthCare Recent Developments
11.21 Philips
11.21.1 Philips Corporation Information
11.21.2 Philips Business Overview
11.21.3 Philips AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.21.4 Philips AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.21.5 Philips Recent Developments
11.22 Olea Medical
11.22.1 Olea Medical Corporation Information
11.22.2 Olea Medical Business Overview
11.22.3 Olea Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.22.4 Olea Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.22.5 Olea Medical Recent Developments
11.23 Methinks AI
11.23.1 Methinks AI Corporation Information
11.23.2 Methinks AI Business Overview
11.23.3 Methinks AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.23.4 Methinks AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.23.5 Methinks AI Recent Developments
11.24 Cercare Medical
11.24.1 Cercare Medical Corporation Information
11.24.2 Cercare Medical Business Overview
11.24.3 Cercare Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.24.4 Cercare Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.24.5 Cercare Medical Recent Developments
11.25 PurpleAI
11.25.1 PurpleAI Corporation Information
11.25.2 PurpleAI Business Overview
11.25.3 PurpleAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.25.4 PurpleAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.25.5 PurpleAI Recent Developments
11.26 Coreline Soft
11.26.1 Coreline Soft Corporation Information
11.26.2 Coreline Soft Business Overview
11.26.3 Coreline Soft AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.26.4 Coreline Soft AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.26.5 Coreline Soft Recent Developments
11.27 mlHealth 360
11.27.1 mlHealth 360 Corporation Information
11.27.2 mlHealth 360 Business Overview
11.27.3 mlHealth 360 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.27.4 mlHealth 360 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.27.5 mlHealth 360 Recent Developments
11.28 NeuroCareAI
11.28.1 NeuroCareAI Corporation Information
11.28.2 NeuroCareAI Business Overview
11.28.3 NeuroCareAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.28.4 NeuroCareAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.28.5 NeuroCareAI Recent Developments
11.29 DEEPNOID
11.29.1 DEEPNOID Corporation Information
11.29.2 DEEPNOID Business Overview
11.29.3 DEEPNOID AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.29.4 DEEPNOID AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.29.5 DEEPNOID Recent Developments
11.30 Yiwei Medical
11.30.1 Yiwei Medical Corporation Information
11.30.2 Yiwei Medical Business Overview
11.30.3 Yiwei Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.30.4 Yiwei Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.30.5 Yiwei Medical Recent Developments
11.31 UnionStrong
11.31.1 UnionStrong Corporation Information
11.31.2 UnionStrong Business Overview
11.31.3 UnionStrong AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.31.4 UnionStrong AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.31.5 UnionStrong Recent Developments
11.32 Cerebriu
11.32.1 Cerebriu Corporation Information
11.32.2 Cerebriu Business Overview
11.32.3 Cerebriu AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.32.4 Cerebriu AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.32.5 Cerebriu Recent Developments
11.33 BrainScan
11.33.1 BrainScan Corporation Information
11.33.2 BrainScan Business Overview
11.33.3 BrainScan AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.33.4 BrainScan AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.33.5 BrainScan Recent Developments
11.34 EverFortune.AI
11.34.1 EverFortune.AI Corporation Information
11.34.2 EverFortune.AI Business Overview
11.34.3 EverFortune.AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.34.4 EverFortune.AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.34.5 EverFortune.AI Recent Developments
11.35 Nunaps
11.35.1 Nunaps Corporation Information
11.35.2 Nunaps Business Overview
11.35.3 Nunaps AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.35.4 Nunaps AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.35.5 Nunaps Recent Developments
11.36 SberMedAI
11.36.1 SberMedAI Corporation Information
11.36.2 SberMedAI Business Overview
11.36.3 SberMedAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.36.4 SberMedAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.36.5 SberMedAI Recent Developments
11.37 NtechLab
11.37.1 NtechLab Corporation Information
11.37.2 NtechLab Business Overview
11.37.3 NtechLab AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.37.4 NtechLab AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.37.5 NtechLab Recent Developments
11.38 Celsus
11.38.1 Celsus Corporation Information
11.38.2 Celsus Business Overview
11.38.3 Celsus AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.38.4 Celsus AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.38.5 Celsus Recent Developments
11.39 Third Opinion
11.39.1 Third Opinion Corporation Information
11.39.2 Third Opinion Business Overview
11.39.3 Third Opinion AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.39.4 Third Opinion AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.39.5 Third Opinion Recent Developments
11.40 Hevi AI
11.40.1 Hevi AI Corporation Information
11.40.2 Hevi AI Business Overview
11.40.3 Hevi AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product Features and Attributes
11.40.4 Hevi AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
11.40.5 Hevi AI Recent Developments

12 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Value Chain and Ecosystem Analysis
12.1 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size Growth Rate by Types of Stroke, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Region (US$ Million), 2021-2026
Table 6. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Region (US$ Million), 2027-2032
Table 7. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 8. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Players (US$ Million), 2021-2026
Table 9. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue-Based Market Share by Players (2021-2026)
Table 10. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 11. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, 2025
Table 12. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Average Gross Margin (%) by Player (2021 vs 2025)
Table 13. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Companies Headquarters
Table 14. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Concentration Ratio (CR5)
Table 15. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 16. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 17. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Type (US$ Million), 2021-2026
Table 18. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Type (US$ Million), 2027-2032
Table 19. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Types of Stroke (US$ Million), 2021-2026
Table 20. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Types of Stroke (US$ Million), 2027-2032
Table 21. Key Product Attributes and Differentiation
Table 22. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Application (US$ Million), 2021-2026
Table 23. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue by Application (US$ Million), 2027-2032
Table 24. AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software High-Growth Sectors Demand CAGR (2026-2032)
Table 25. Top Customers by Region
Table 26. Top Customers by Application
Table 27. North America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Growth Accelerators and Market Barriers
Table 28. North America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 29. Europe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Growth Accelerators and Market Barriers
Table 30. Europe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Asia-Pacific AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Growth Accelerators and Market Barriers
Table 32. Asia-Pacific AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Central and South America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Investment Opportunities and Key Challenges
Table 34. Central and South America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 35. Middle East and Africa AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Investment Opportunities and Key Challenges
Table 36. Middle East and Africa AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 37. RapidAI Corporation Information
Table 38. RapidAI Description and Major Businesses
Table 39. RapidAI Product Features and Attributes
Table 40. RapidAI Revenue (US$ Million) and Gross Margin (2021-2026)
Table 41. RapidAI Revenue Proportion by Product in 2025
Table 42. RapidAI Revenue Proportion by Application in 2025
Table 43. RapidAI Revenue Proportion by Geographic Area in 2025
Table 44. RapidAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software SWOT Analysis
Table 45. RapidAI Recent Developments
Table 46. Viz.ai Corporation Information
Table 47. Viz.ai Description and Major Businesses
Table 48. Viz.ai Product Features and Attributes
Table 49. Viz.ai Revenue (US$ Million) and Gross Margin (2021-2026)
Table 50. Viz.ai Revenue Proportion by Product in 2025
Table 51. Viz.ai Revenue Proportion by Application in 2025
Table 52. Viz.ai Revenue Proportion by Geographic Area in 2025
Table 53. Viz.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software SWOT Analysis
Table 54. Viz.ai Recent Developments
Table 55. Brainomix Corporation Information
Table 56. Brainomix Description and Major Businesses
Table 57. Brainomix Product Features and Attributes
Table 58. Brainomix Revenue (US$ Million) and Gross Margin (2021-2026)
Table 59. Brainomix Revenue Proportion by Product in 2025
Table 60. Brainomix Revenue Proportion by Application in 2025
Table 61. Brainomix Revenue Proportion by Geographic Area in 2025
Table 62. Brainomix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software SWOT Analysis
Table 63. Brainomix Recent Developments
Table 64. Aidoc Corporation Information
Table 65. Aidoc Description and Major Businesses
Table 66. Aidoc Product Features and Attributes
Table 67. Aidoc Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Aidoc Revenue Proportion by Product in 2025
Table 69. Aidoc Revenue Proportion by Application in 2025
Table 70. Aidoc Revenue Proportion by Geographic Area in 2025
Table 71. Aidoc AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software SWOT Analysis
Table 72. Aidoc Recent Developments
Table 73. JLK Corporation Information
Table 74. JLK Description and Major Businesses
Table 75. JLK Product Features and Attributes
Table 76. JLK Revenue (US$ Million) and Gross Margin (2021-2026)
Table 77. JLK Revenue Proportion by Product in 2025
Table 78. JLK Revenue Proportion by Application in 2025
Table 79. JLK Revenue Proportion by Geographic Area in 2025
Table 80. JLK AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software SWOT Analysis
Table 81. JLK Recent Developments
Table 82. Qure.ai Corporation Information
Table 83. Qure.ai Description and Major Businesses
Table 84. Qure.ai Product Features and Attributes
Table 85. Qure.ai Revenue (US$ Million) and Gross Margin (2021-2026)
Table 86. Qure.ai Recent Developments
Table 87. United Imaging Intelligence Corporation Information
Table 88. United Imaging Intelligence Description and Major Businesses
Table 89. United Imaging Intelligence Product Features and Attributes
Table 90. United Imaging Intelligence Revenue (US$ Million) and Gross Margin (2021-2026)
Table 91. United Imaging Intelligence Recent Developments
Table 92. Infervision Corporation Information
Table 93. Infervision Description and Major Businesses
Table 94. Infervision Product Features and Attributes
Table 95. Infervision Revenue (US$ Million) and Gross Margin (2021-2026)
Table 96. Infervision Recent Developments
Table 97. Shukun Technology Corporation Information
Table 98. Shukun Technology Description and Major Businesses
Table 99. Shukun Technology Product Features and Attributes
Table 100. Shukun Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 101. Shukun Technology Recent Developments
Table 102. Heuron Corporation Information
Table 103. Heuron Description and Major Businesses
Table 104. Heuron Product Features and Attributes
Table 105. Heuron Revenue (US$ Million) and Gross Margin (2021-2026)
Table 106. Heuron Recent Developments
Table 107. Siemens Healthineers Corporation Information
Table 108. Siemens Healthineers Description and Major Businesses
Table 109. Siemens Healthineers Product Features and Attributes
Table 110. Siemens Healthineers Revenue (US$ Million) and Gross Margin (2021-2026)
Table 111. Siemens Healthineers Recent Developments
Table 112. Circle CVI Corporation Information
Table 113. Circle CVI Description and Major Businesses
Table 114. Circle CVI Product Features and Attributes
Table 115. Circle CVI Revenue (US$ Million) and Gross Margin (2021-2026)
Table 116. Circle CVI Recent Developments
Table 117. Avicenna.AI Corporation Information
Table 118. Avicenna.AI Description and Major Businesses
Table 119. Avicenna.AI Product Features and Attributes
Table 120. Avicenna.AI Revenue (US$ Million) and Gross Margin (2021-2026)
Table 121. Avicenna.AI Recent Developments
Table 122. Nicolab Corporation Information
Table 123. Nicolab Description and Major Businesses
Table 124. Nicolab Product Features and Attributes
Table 125. Nicolab Revenue (US$ Million) and Gross Margin (2021-2026)
Table 126. Nicolab Recent Developments
Table 127. icometrix Corporation Information
Table 128. icometrix Description and Major Businesses
Table 129. icometrix Product Features and Attributes
Table 130. icometrix Revenue (US$ Million) and Gross Margin (2021-2026)
Table 131. icometrix Recent Developments
Table 132. Harrison.ai Corporation Information
Table 133. Harrison.ai Description and Major Businesses
Table 134. Harrison.ai Product Features and Attributes
Table 135. Harrison.ai Revenue (US$ Million) and Gross Margin (2021-2026)
Table 136. Harrison.ai Recent Developments
Table 137. Deepwise Corporation Information
Table 138. Deepwise Description and Major Businesses
Table 139. Deepwise Product Features and Attributes
Table 140. Deepwise Revenue (US$ Million) and Gross Margin (2021-2026)
Table 141. Deepwise Recent Developments
Table 142. Neusoft Medical Corporation Information
Table 143. Neusoft Medical Description and Major Businesses
Table 144. Neusoft Medical Product Features and Attributes
Table 145. Neusoft Medical Revenue (US$ Million) and Gross Margin (2021-2026)
Table 146. Neusoft Medical Recent Developments
Table 147. BioMind Corporation Information
Table 148. BioMind Description and Major Businesses
Table 149. BioMind Product Features and Attributes
Table 150. BioMind Revenue (US$ Million) and Gross Margin (2021-2026)
Table 151. BioMind Recent Developments
Table 152. GE HealthCare Corporation Information
Table 153. GE HealthCare Description and Major Businesses
Table 154. GE HealthCare Product Features and Attributes
Table 155. GE HealthCare Revenue (US$ Million) and Gross Margin (2021-2026)
Table 156. GE HealthCare Recent Developments
Table 157. Philips Corporation Information
Table 158. Philips Description and Major Businesses
Table 159. Philips Product Features and Attributes
Table 160. Philips Revenue (US$ Million) and Gross Margin (2021-2026)
Table 161. Philips Recent Developments
Table 162. Olea Medical Corporation Information
Table 163. Olea Medical Description and Major Businesses
Table 164. Olea Medical Product Features and Attributes
Table 165. Olea Medical Revenue (US$ Million) and Gross Margin (2021-2026)
Table 166. Olea Medical Recent Developments
Table 167. Methinks AI Corporation Information
Table 168. Methinks AI Description and Major Businesses
Table 169. Methinks AI Product Features and Attributes
Table 170. Methinks AI Revenue (US$ Million) and Gross Margin (2021-2026)
Table 171. Methinks AI Recent Developments
Table 172. Cercare Medical Corporation Information
Table 173. Cercare Medical Description and Major Businesses
Table 174. Cercare Medical Product Features and Attributes
Table 175. Cercare Medical Revenue (US$ Million) and Gross Margin (2021-2026)
Table 176. Cercare Medical Recent Developments
Table 177. PurpleAI Corporation Information
Table 178. PurpleAI Description and Major Businesses
Table 179. PurpleAI Product Features and Attributes
Table 180. PurpleAI Revenue (US$ Million) and Gross Margin (2021-2026)
Table 181. PurpleAI Recent Developments
Table 182. Coreline Soft Corporation Information
Table 183. Coreline Soft Description and Major Businesses
Table 184. Coreline Soft Product Features and Attributes
Table 185. Coreline Soft Revenue (US$ Million) and Gross Margin (2021-2026)
Table 186. Coreline Soft Recent Developments
Table 187. mlHealth 360 Corporation Information
Table 188. mlHealth 360 Description and Major Businesses
Table 189. mlHealth 360 Product Features and Attributes
Table 190. mlHealth 360 Revenue (US$ Million) and Gross Margin (2021-2026)
Table 191. mlHealth 360 Recent Developments
Table 192. NeuroCareAI Corporation Information
Table 193. NeuroCareAI Description and Major Businesses
Table 194. NeuroCareAI Product Features and Attributes
Table 195. NeuroCareAI Revenue (US$ Million) and Gross Margin (2021-2026)
Table 196. NeuroCareAI Recent Developments
Table 197. DEEPNOID Corporation Information
Table 198. DEEPNOID Description and Major Businesses
Table 199. DEEPNOID Product Features and Attributes
Table 200. DEEPNOID Revenue (US$ Million) and Gross Margin (2021-2026)
Table 201. DEEPNOID Recent Developments
Table 202. Yiwei Medical Corporation Information
Table 203. Yiwei Medical Description and Major Businesses
Table 204. Yiwei Medical Product Features and Attributes
Table 205. Yiwei Medical Revenue (US$ Million) and Gross Margin (2021-2026)
Table 206. Yiwei Medical Recent Developments
Table 207. UnionStrong Corporation Information
Table 208. UnionStrong Description and Major Businesses
Table 209. UnionStrong Product Features and Attributes
Table 210. UnionStrong Revenue (US$ Million) and Gross Margin (2021-2026)
Table 211. UnionStrong Recent Developments
Table 212. Cerebriu Corporation Information
Table 213. Cerebriu Description and Major Businesses
Table 214. Cerebriu Product Features and Attributes
Table 215. Cerebriu Revenue (US$ Million) and Gross Margin (2021-2026)
Table 216. Cerebriu Recent Developments
Table 217. BrainScan Corporation Information
Table 218. BrainScan Description and Major Businesses
Table 219. BrainScan Product Features and Attributes
Table 220. BrainScan Revenue (US$ Million) and Gross Margin (2021-2026)
Table 221. BrainScan Recent Developments
Table 222. EverFortune.AI Corporation Information
Table 223. EverFortune.AI Description and Major Businesses
Table 224. EverFortune.AI Product Features and Attributes
Table 225. EverFortune.AI Revenue (US$ Million) and Gross Margin (2021-2026)
Table 226. EverFortune.AI Recent Developments
Table 227. Nunaps Corporation Information
Table 228. Nunaps Description and Major Businesses
Table 229. Nunaps Product Features and Attributes
Table 230. Nunaps Revenue (US$ Million) and Gross Margin (2021-2026)
Table 231. Nunaps Recent Developments
Table 232. SberMedAI Corporation Information
Table 233. SberMedAI Description and Major Businesses
Table 234. SberMedAI Product Features and Attributes
Table 235. SberMedAI Revenue (US$ Million) and Gross Margin (2021-2026)
Table 236. SberMedAI Recent Developments
Table 237. NtechLab Corporation Information
Table 238. NtechLab Description and Major Businesses
Table 239. NtechLab Product Features and Attributes
Table 240. NtechLab Revenue (US$ Million) and Gross Margin (2021-2026)
Table 241. NtechLab Recent Developments
Table 242. Celsus Corporation Information
Table 243. Celsus Description and Major Businesses
Table 244. Celsus Product Features and Attributes
Table 245. Celsus Revenue (US$ Million) and Gross Margin (2021-2026)
Table 246. Celsus Recent Developments
Table 247. Third Opinion Corporation Information
Table 248. Third Opinion Description and Major Businesses
Table 249. Third Opinion Product Features and Attributes
Table 250. Third Opinion Revenue (US$ Million) and Gross Margin (2021-2026)
Table 251. Third Opinion Recent Developments
Table 252. Hevi AI Corporation Information
Table 253. Hevi AI Description and Major Businesses
Table 254. Hevi AI Product Features and Attributes
Table 255. Hevi AI Revenue (US$ Million) and Gross Margin (2021-2026)
Table 256. Hevi AI Recent Developments
Table 257. Technologies, Platforms and Infrastructure
Table 258. Distributors List
Table 259. Market Trends and Market Evolution
Table 260. Market Drivers and Opportunities
Table 261. Market Challenges, Risks, and Restraints
Table 262. Research Programs/Design for This Report
Table 263. Key Data Information from Secondary Sources
Table 264. Key Data Information from Primary Sources

List of Figures
Figure 1. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Non-Contrast CT Software Product Picture
Figure 3. CT Angiography Software Product Picture
Figure 4. CT Perfusion Software Product Picture
Figure 5. MRI Software Product Picture
Figure 6. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size Growth Rate by Types of Stroke, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Ischemic Stroke Analysis Software Product Picture
Figure 8. Hemorrhagic Stroke Analysis Software Product Picture
Figure 9. Comprehensive Stroke Analysis Software Product Picture
Figure 10. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 11. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. Pre-Hospital Emergency Care
Figure 13. Hospital Stroke Center
Figure 14. Primary Healthcare Institutions
Figure 15. Regional Stroke Collaborative Treatment Network
Figure 16. AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Report Years Considered
Figure 17. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 19. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 20. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue-Based Market Share by Region (2021-2032)
Figure 21. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue-Based Market Share Ranking (2025)
Figure 22. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 23. Non-Contrast CT Software Revenue-Based Market Share by Player in 2025
Figure 24. CT Angiography Software Revenue-Based Market Share by Player in 2025
Figure 25. CT Perfusion Software Revenue-Based Market Share by Player in 2025
Figure 26. MRI Software Revenue-Based Market Share by Player in 2025
Figure 27. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue-Based Market Share by Type (2021-2032)
Figure 28. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue-Based Market Share by Types of Stroke (2021-2032)
Figure 29. Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue-Based Market Share by Application (2021-2032)
Figure 30. North America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue YoY (US$ Million), 2021-2032
Figure 31. North America Top 5 Players AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million) in 2025
Figure 32. North America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million) by Application (2021-2032)
Figure 33. US AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 34. Canada AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 35. Mexico AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 36. Europe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue YoY (US$ Million), 2021-2032
Figure 37. Europe Top 5 Players AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million) in 2025
Figure 38. Europe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million) by Application (2021-2032)
Figure 39. Germany AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 40. France AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 41. U.K. AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 42. Italy AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 43. Russia AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 44. Asia-Pacific AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue YoY (US$ Million), 2021-2032
Figure 45. Asia-Pacific Top 8 Players AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million) in 2025
Figure 46. Asia-Pacific AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million) by Application (2021-2032)
Figure 47. Indonesia AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 48. Japan AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 49. South Korea AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 50. Australia AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 51. India AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 52. Indonesia AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 53. Vietnam AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 54. Malaysia AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 55. Philippines AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 56. Singapore AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 57. Central and South America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue YoY (US$ Million), 2021-2032
Figure 58. Central and South America Top 5 Players AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million) in 2025
Figure 59. Central and South America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million) by Application (2021-2032)
Figure 60. Brazil AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 61. Argentina AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 62. Middle East and Africa AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue YoY (US$ Million), 2021-2032
Figure 63. Middle East and Africa Top 5 Players AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million) in 2025
Figure 64. Middle East and Africa AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million) by Application (2021-2032)
Figure 65. GCC Countries AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 66. Israel AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 67. Egypt AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 68. South Africa AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue (US$ Million), 2021-2032
Figure 69. AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Value Chain Mapping
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed